The role of the ErbB2/PI3-K/Akt1 pathway in antiestrogen resistance

被引：0
|
作者：
Stoica, Adriana [1 ]
Clarke, Robert [1 ]
Simoneaux, Michael [1 ]
Summe, Heather [1 ]
Proskine, Molly [1 ]
Fagel, Jennifer [1 ]
Muesli, Camelia [1 ]
Evans, Charles H., Jr. [1 ]
Russell, Robert [1 ]
机构：
[1] Georgetown Univ, Washington, DC USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2939
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Promotion of metastasis of ERBB2-positive breast cancer by mesenchymal stem cells via exosomes-mediated activation of ERBB2/ERBB3. PI3K/Akt singaling pathway
    Wu, Yating
    Chen, Li
    Cao, Yue
    Huang, Qinfeng
    Niu, Huimin
    Lai, Xiaofeng
    Zhao, Meng
    Yan, Huihui
    Lyu, Hui
    Liu, Bolin
    Zhang, Shenghang
    Wang, Shuiliang
    CANCER RESEARCH, 2024, 84 (06)
  • [32] Oleate induces an insulin resistance 'selective' for the PI3-K/Akt pathway in cultured human vascular smooth muscle cells
    Russo, I.
    Del Mese, P.
    Viretto, M.
    Doronzo, G.
    Mattiello, L.
    Anfossi, G.
    Trovati, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 : 55 - 55
  • [33] The Role of the PI3K-AKT Pathway in Melanoma
    Davies, Michael A.
    CANCER JOURNAL, 2012, 18 (02): : 142 - 147
  • [34] Role of GSK-3β in Regulation of Canonical Wnt/β-catenin Signaling and PI3-K/Akt Oncogenic Pathway in Colon Cancer
    Jain, Shelly
    Ghanghas, Preety
    Rana, Chandan
    Sanyal, S. N.
    CANCER INVESTIGATION, 2017, 35 (07) : 473 - 483
  • [35] Activation of the PI3K/Akt pathway and chemotherapeutic resistance
    West, KA
    Castillo, SS
    Dennis, PA
    DRUG RESISTANCE UPDATES, 2002, 5 (06) : 234 - 248
  • [36] The Role of ERBB2/ERBB3 Signal Pathway in Generation of Cancer Stem Cells
    Hassan, Ghmkin
    Seno, Masaharu
    CANCER SCIENCE, 2021, 112 : 281 - 281
  • [37] Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer
    Sokolowski, Kevin M.
    Koprowski, Steven
    Kunnimalaiyaan, Selvi
    Balamurugan, Mariappan
    Gamblin, T. Clark
    Kunnimalaiyaan, Muthusamy
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (01) : 29 - 37
  • [38] Lumiliximab Triggers Apoptosis Mechanisms in CLL Cells through the Inhibition of PI3-K/Akt Pathway
    Shehata, Medhat
    Schnabl, Susanne
    Ponath, Elena
    Tauber, Stefanie
    Demirtas, Dita
    Hilgarth, Martin
    Bilban, Martin
    Badrnya, Sigrun
    Fleiss, Karin
    Schwarzmeier, Josef D.
    Gaiger, Alexander
    Hubmann, Rainer
    Zielinski, Christoph C.
    Hughes, Steve
    Maclaren, Ann
    Jaeger, Ulrich
    BLOOD, 2009, 114 (22) : 936 - 936
  • [39] PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation
    Tibes, Raoul
    Kornblau, Steven M.
    Qiu, Yihua
    Mousses, Spyro M.
    Robbins, Christiane
    Moses, Tracy
    Carpten, John D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 140 (03) : 344 - 347
  • [40] PI3-K/Akt pathway contributes to IL-6-dependent growth of 7TD1 cells
    Zhang, JiYan
    Li, Yan
    Shen, BeiFen
    CANCER CELL INTERNATIONAL, 2003, 3 (1)
12345